Treatment of axillary hyperhidrosis with botulinum toxin type A reconstituted in lidocaine or in normal saline: A randomized, side-by-side, double-blind study

British Journal of Dermatology

Volumn 156, Issue 5, 2007, Pages 986-989

  Vadoud Seyedi, J ^a   Simonart, T ^a  

^a ERASME HOSPITAL   (Belgium)

Author keywords

Botulinum toxin; Hyperhidrosis; Lidocaine; Pain; Randomized controlled trial

Indexed keywords

BOTULINUM TOXIN A; IODINE; LIDOCAINE; SODIUM CHLORIDE; STARCH;

ADULT; ARTICLE; AXILLA; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG TOLERABILITY; FATIGUE; FEMALE; FOLLOW UP; HEMATOMA; HUMAN; HYPERHIDROSIS; INJECTION SITE PAIN; MALE; PAIN ASSESSMENT; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SELF EVALUATION; SWEATING; TREATMENT DURATION; TREATMENT OUTCOME; VISUAL ANALOG SCALE;

ADOLESCENT; ADULT; ANESTHETICS, LOCAL; AXILLA; BOTULINUM TOXIN TYPE A; DOUBLE-BLIND METHOD; DRUG COMBINATIONS; FEMALE; HUMANS; HYPERHIDROSIS; INJECTIONS, INTRADERMAL; LIDOCAINE; MALE; MIDDLE AGED; NEUROMUSCULAR AGENTS; PAIN; SODIUM CHLORIDE; TREATMENT OUTCOME;

EID: 34247368075     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2007.07760.x     Document Type: Article

References (18)

1. Sato K, Kang WH, Saga K, Sato KT. Biology of sweat glands and their disorders. II. Disorders of sweat gland function. J Am Acad Dermatol 1989 20:713 26.
2. Weber A, Heger S, Sinkgraven R et al. Psychosocial aspects of patients with focal hyperhidrosis. Marked reduction of social phobia, anxiety and depression and increased quality of life after treatment with botulinum toxin A. Br J Dermatol 2005 152:342 5.
3. Schnider P, Binder M, Kittler H et al. A randomized, double-blind, placebo-controlled trial of botulinum A toxin for severe axillary hyperhidrosis. Br J Dermatol 1999 140:677 80.
4. Vadoud-Seyedi J, Heenen M, Simonart T. Treatment of idiopathic palmar hyperhidrosis with botulinum toxin. Report of 23 cases and review of the literature. Dermatology 2001 203:318 21.
5. Lowe N, Campanati A, Bodokh I et al. The place of botulinum toxin type A in the treatment of focal hyperhidrosis. Br J Dermatol 2004 151:1115 22.
6. Glogau RC. Treatment of hyperhidrosis with botulinum toxin. Dermatol Clin 2004 22:177 85.
7. Hayton MJ, Stanley JK, Lowe NJ. A review of peripheral nerve blockade as local anaesthesia in the treatment of palmar hyperhidrosis. Br J Dermatol 2003 149:447 51.
8. O'Riordan JM, Fitzgerald E, Gowing C et al. Topical local anaesthetic (tetracaine) reduces pain from botulinum toxin injections for axillary hyperhidrosis. Br J Surg 2006 93:713 14.
9. Allergan Inc. Botox® Package Insert. Westport, County Mayo:Allergan Pharmaceuticals Ireland, 2000.
10. Heckmann M, Plewig G Hyperhidrosis Study Group. Low-dose efficacy of botulinum toxin A for axillary hyperhidrosis: a randomized, side-by-side, open-label study. Arch Dermatol 2005 141:1255 9.
11. Glaser DA. Treatment of axillary hyperhidrosis by chemodenervation of sweat glands using botulinum toxin type A. J Drugs Dermatol 2004 3:627 31.
12. Wollina U, Karamfilov T, Konrad H. High-dose botulinum toxin type A therapy for axillary hyperhidrosis markedly prolongs the relapse-free interval. J Am Acad Dermatol 2002 46:536 40.
13. Naumann M, Hofmann U, Bergmann I et al. Focal hyperhidrosis: effective treatment with intracutaneous botulinum toxin. Arch Dermatol 1998 134:301 4.
14. Carlsson AM. Assessment of chronic pain. I. Aspects of the reliability and validity of the visual analogue scale. Pain 1983 16:87 101.
15. Gassner HG, Sherris DA. Addition of an anesthetic agent to enhance the predictability of the effects of botulinum toxin type A injections: a randomized controlled study. Mayo Clin Proc 2000 75:701 4.
16. Berkun Y, Ben-Zvi A, Levy Y et al. Evaluation of adverse reactions to local anesthetics: experience with 236 patients. Ann Allergy Asthma Immunol 2003 91:342 5.
17. Amsler E, Flahault A, Mathelier-Fusade P, Aractingi S. Evaluation of re-challenge in patients with suspected lidocaine allergy. Dermatology 2004 208:109 11.
18. Li M, Goldberger BA, Hopkins C. Fatal case of BOTOX-related anaphylaxis? J Forensic Sci 2005 50:169 72.